Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levels

Nature Genetics

Volumn 47, Issue 11, 2015, Pages 1264-1271

  Danjou, Fabrice ^a   Zoledziewska, Magdalena ^a   Sidore, Carlo ^a,b,c   Steri, Maristella ^a   Busonero, Fabio ^a,b   Maschio, Andrea ^a,b   Mulas, Antonella ^a,c   Perseu, Lucia ^a   Barella, Susanna ^d   Porcu, Eleonora ^a,b,c   Pistis, Giorgio ^a,b,c   Pitzalis, Maristella ^a   Pala, Mauro ^a   Menzel, Stephan ^e   Metrustry, Sarah ^e   Spector, Timothy D ^e   Leoni, Lidia ^f   Angius, Andrea ^a,f   Uda, Manuela ^a   Moi, Paolo ^d,g   Thein, Swee Lay ^e,h   Galanello, Renzo ^d,g   Abecasis, Gonçalo R ^b   Schlessinger, David ⁱ   Sanna, Serena ^a   Cucca, Francesco ^a,c   more..

^a Milan Unit   (Italy)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF SASSARI   (Italy)

^d Osp Regionale per le Microcitemie   (Italy)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f CENTER FOR ADVANCED STUDIES   (Italy)

^g UNIVERSITY OF CAGLIARI   (Italy)

^h KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN A1C; HEMOGLOBIN A2; HEMOGLOBIN F; RNA POLYMERASE II; TRANSCRIPTION FACTOR GATA; TRIACYLGLYCEROL; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN;

ARTICLE; ERYTHROCYTE VOLUME; ERYTHROPOIESIS; GENE FREQUENCY; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; GLOBIN GENE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; PHENOTYPIC VARIATION; PLEIOTROPY; POPULATION; PRIORITY JOURNAL; STOP CODON; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; DNA SEQUENCE; FEMALE; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUE; HUMAN GENOME; ISLAND (GEOLOGICAL); ITALY; MALE; MIDDLE AGED; MULTIGENE FAMILY; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALPHA-GLOBINS; BETA-GLOBINS; FEMALE; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GENOTYPING TECHNIQUES; HEMOGLOBINS; HUMANS; ISLANDS; ITALY; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84945346364     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3307     Document Type: Article

References (82)

1. Sankaran, V.G., Xu, J., & Orkin, S.H. Advances in the understanding of haemoglobin switching. Br. J. Haematol. 149, 181-194 (2010).
2. Modell, B., & Darlison, M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull. World Health Organ. 86, 480-487 (2008).
3. Malaria Genomic Epidemiology Network. Reappraisal of known malaria resistance loci in a large multicenter study. Nat. Genet. 46, 1197-1204 (2014).
4. Pilia, G., et al. Heritability of cardiovascular and personality traits in 6, 148 Sardinians. PLoS Genet. 2, e132 (2006).
5. Menzel, S., Garner, C., Rooks, H., Spector, T.D., & Thein, S.L. HbA2 levels in normal adults are influenced by two distinct genetic mechanisms. Br. J. Haematol. 160, 101-105 (2013).
6. Bae, H.T., et al. Meta-Analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 120, 1961-1962 (2012).
7. Uda, M., et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of b-Dhalassemia. Proc. Natl. Acad. Sci. USA 105, 1620-1625 (2008).
8. Lettre, G., et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and b-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl. Acad. Sci. USA 105, 11869-11874 (2008).
9. Danjou, F., et al. Genetic modifiers of b-Dhalassemia and clinical severity as assessed by age at first transfusion. Haematologica 97, 989-993 (2012).
10. Danjou, F., et al. A genetic score for the prediction of b-Dhalassemia severity. Haematologica 100, 452-457 (2015).
11. van der Harst, P., et al. Seventy-five genetic loci influencing the human red blood cell. Nature 492, 369-375 (2012).
12. Trecartin, R.F., et al. Beta zero thalassemia in Sardinia is caused by a nonsense mutation. J. Clin. Invest. 68, 1012-1017 (1981).
13. Sidore C., et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat. Genet. doi:10.1038/ng.3368 14 September 2015).
14. Kircher, M., et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310-315 (2014).
15. Freson, K., et al. Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions. Hum. Genet. 112, 42-49 (2003).
16. Nichols, K.E., et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat. Genet. 24, 266-270 (2000).
17. Kozar, K., et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118, 477-491 (2004).
18. Sankaran, V.G., et al. Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number. Genes Dev. 26, 2075-2087 (2012).
19. Soranzo, N., et al. A genome-wide meta-Analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat. Genet. 41, 1182-1190 (2009).
20. Kamatani, Y., et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 42, 210-215 (2010).
21. Kathiresan, S., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56-65 (2009).
22. Jarvik, G.P., et al. Genetic and nongenetic sources of variation in phospholipid transfer protein activity. J. Lipid Res. 51, 983-990 (2010).
23. Lettre, G., et al. Genome-wide association study of coronary heart disease and its risk factors in 8, 090 African Americans: the NHLBI CARe Project. PLoS Genet. 7, e1001300 (2011).
24. Kettunen, J., et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat. Genet. 44, 269-276 (2012).
25. Hirose, Y., et al. Human phosphorylated CTD-interacting protein, PCIF1, negatively modulates gene expression by RNA polymerase II. Biochem. Biophys. Res. Commun. 369, 449-455 (2008).
26. Lessard, S., Beaudoin, M., Benkirane, K., & Lettre, G. Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitors. Genome Med. 7, 1 (2015).
27. Riddell, J., et al. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 157, 549-564 (2014).
28. Holmfeldt, P., et al. Nfix is a novel regulator of murine hematopoietic stem and progenitor cell survival. Blood 122, 2987-2996 (2013).
29. Kawane, K., et al. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science 292, 1546-1549 (2001).
30. Porcu, S., et al. Klf1 affects DNase IIa expression in the central macrophage of a fetal liver erythroblastic island: a non-cell-Autonomous role in definitive erythropoiesis. Mol. Cell. Biol. 31, 4144-4154 (2011).
31. Zhou, D., Liu, K., Sun, C.-W., Pawlik, K.M., & Townes, T.M. KLF1 regulates BCL11A expression and γ-Do b-globin gene switching. Nat. Genet. 42, 742-744 (2010).
32. Siatecka, M., & Bieker, J.J. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood 118, 2044-2054 (2011).
33. Satta, S., et al. Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin. Haematologica 96, 767-770 (2011).
34. Borg, J., et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat. Genet. 42, 801-805 (2010).
35. Perseu, L., et al. KLF1 gene mutations cause borderline HbA2. Blood 118, 4454-4458 (2011).
36. A1000 Genomes Project Consortium. An integrated map of genetic variation from 1, 092 human genomes. Nature 491, 56-65 (2012).
37. Su, A.I., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101, 6062-6067 (2004).
38. Ashburner, M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (2000).
39. Raychaudhuri, S., et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 5, e1000534 (2009).
40. Andrews, N.C. The NF-E2 transcription factor. Int. J. Biochem. Cell Biol. 30, 429-432 (1998).
41. Hoogewijs, D., et al. Androglobin: a chimeric globin in metazoans that is preferentially expressed in Mammalian testes. Mol. Biol. Evol. 29, 1105-1114 (2012).
42. Iolascon, A., Perrotta, S., & Stewart, G.W. Red blood cell membrane defects. Rev. Clin. Exp. Hematol. 7, 22-56 (2003).
43. Moayyeri, A., Hammond, C.J., Valdes, A.M., & Spector, T.D. Cohort profile: TwinsUK and Healthy Ageing Twin Study. Int. J. Epidemiol. 42, 76-85 (2013).
44. Sangerman, J., et al. Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves γ-globin activation by CREB1 and ATF-2. Blood 108, 3590-3599 (2006).
45. Goh, S.-H., et al. A newly discovered human a-globin gene. Blood 106, 1466-1472 (2005).
46. Farrell, J.J., et al. A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood 117, 4935-4945 (2011).
47. Stadhouders, R., et al. HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. J. Clin. Invest. 124, 1699-1710 (2014).
48. Zeller, T., et al. Genetics and beyond-Dhe transcriptome of human monocytes and disease susceptibility. PLoS ONE 5, e10693 (2010).
49. Bhatnagar, P., et al. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J. Hum. Genet. 56, 316-323 (2011).
50. Bauer, D.E., & Orkin, S.H. Update on fetal hemoglobin gene regulation in hemoglobinopathies. Curr. Opin. Pediatr. 23, 1-8 (2011).
51. Bauer, D.E., et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342, 253-257 (2013).
52. Grundberg, E., et al. Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-Associated variants in distal regulatory elements. Am. J. Hum. Genet. 93, 876-890 (2013).
53. Karolchik, D., et al. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res. 42, D764-D770 (2014).
54. Rosenbloom, K.R., et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 41, D56-D63 (2013).
55. Steinberg, M.H., & Adams, J.G. Hemoglobin A2: origin, evolution, and aftermath. Blood 78, 2165-2177 (1991).
56. Pistis, G., et al. Rare variant genotype imputation with thousands of study-specific whole-genome sequences: implications for cost-effective study designs. Eur. J. Hum. Genet. 23, 975-983 (2015).
57. Goldstein, J.I., et al. zCall: a rare variant caller for array-based genotyping: genetics and population analysis. Bioinformatics 28, 2543-2545 (2012).
58. Li, Y., Willer, C.J., Ding, J., Scheet, P., & Abecasis, G.R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816-834 (2010).
59. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., & Abecasis, G.R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012).
60. Kang, H.M., et al. Variance component model to account for sample structure in genome-wide association studies. Nat. Genet. 42, 348-354 (2010).
61. Abecasis, G.R., Cherny, S.S., Cookson, W.O., & Cardon, L.R. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 30, 97-101 (2002).
62. R Core Development Team R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing 2013).
63. Origa, R., et al. Complexity of the a-globin genotypes identified with thalassemia screening in Sardinia. Blood Cells Mol. Dis. 52, 46-49 (2014).
64. Naitza, S., et al. A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet. 8, e1002480 (2012).
65. Howie, B.N., Donnelly, P., & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
66. Menzel, S., et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 39, 1197-1199 (2007).
67. Myers, A.J., et al. A survey of genetic human cortical gene expression. Nat. Genet. 39, 1494-1499 (2007).
68. Stranger, B.E., et al. Population genomics of human gene expression. Nat. Genet. 39, 1217-1224 (2007).
69. Veyrieras, J.-B., et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 4, e1000214 (2008).
70. Dimas, A.S., et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325, 1246-1250 (2009).
71. Pickrell, J.K., et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464, 768-772 (2010).
72. Fehrmann, R.S.N. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet. 7, e1002197 (2011).
73. Innocenti, F., et al. Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue. PLoS Genet. 7, e1002078 (2011).
74. Montgomery, S.B., Lappalainen, T., Gutierrez-Arcelus, M., & Dermitzakis, E.T. Rare and common regulatory variation in population-scale sequenced human genomes. PLoS Genet. 7, e1002144 (2011).
75. Degner, J.F., et al. DNaseI sensitivity QTLs are a major determinant of human expression variation. Nature 482, 390-394 (2012).
76. Gaffney, D.J., et al. Dissecting the regulatory architecture of gene expression QTLs. Genome Biol. 13, R7 (2012).
77. Wright, F.A., Shabalin, A.A., & Rusyn, I. Computational tools for discovery and interpretation of expression quantitative trait loci. Pharmacogenomics 13, 343-352 (2012).
78. Lappalainen, T., et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501, 506-511 (2013).
79. Westra, H.-J., et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238-1243 (2013).
80. Battle, A., et al. Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res. 24, 14-24 (2014).
81. Fairfax, B.P., et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014).
82. Willer, C.J., Li, Y., & Abecasis, G.R. METAL: fast and efficient meta-Analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).